About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Arizona | 707 Studies

Clinical Trials Breast CancerArizona

Breast Cancer Clinical Trials in Arizona

Find 707 clinical trials for breast cancer near Arizona. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Arizona

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 421-440 of 707 trials

CompletedLS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast CancerThe aim of this Phase 1b/2 study is to investigate the safety, efficacy, and pharmacokinetics (PK) of a single dose of LS301-IT, a novel fluorescence imaging agent developed by…NCT05900986·Scottsdale, Arizona and 8 others CompletedSulindac in Preventing Breast Cancer in Women at High Risk for Breast CancerRATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of sulindac may prevent breast cancer.NCT00245024·Tucson, Arizona Active not recruitingExcision Followed by Radiofrequency Ablation for Breast CancerThe purpose of this study will be to evaluate, in a multi-center setting, the ability of radiofrequency ablation (RFA) of breast cancer lumpectomy sites to extend the "final"…NCT01153035·Tucson, Arizona and 5 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedTrial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast CancerTo determine whether the combination MM-121 + Exemestane in ER+ and/or PR+ breast cancer patients is more effective than Exemestane aloneNCT01151046·Birmingham, Alabama and 32 others

TerminatedA Safety Study of SEA-TGT (SGN-TGT) in Advanced CancerThis trial will look at a drug called SEA-TGT (also known as SGN-TGT) to find out whether it is safe for patients with solid tumors and lymphomas.NCT04254107·Birmingham, Alabama and 35 others

CompletedNSAID Effects on Clinical and Imaging Breast BiomarkersThis study has two purposes. One is to determine if daily sulindac decreases breast density; a risk factor for breast cancer development.NCT01761877·Tucson, Arizona and 1 other

CompletedScreening CEDM in Intermediate and High-Risk Patient PopulationsThis research study is being done to determine if Contrast Enhanced Digital Mammography (CEDM) can improve breast cancer detection and can be used as an additional screening…NCT03859492·Scottsdale, Arizona

WithdrawnProspective Comparison of Breast MRI vs Contrast Mammography Prior to Surgery in Breast Cancer PatientsIn current clinical practice, women with biopsy proven breast cancer can be sent for breast magnetic resonance imaging (MRI) or contrast enhanced mammography (CEM) prior to…NCT04770714·Phoenix, Arizona

CompletedAccelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After SurgeryThis phase II trial studies how well accelerated partial breast irradiation (APBI) using high-dose rate (HDR) brachytherapy works in treating patients with breast cancer that has…NCT02526498·Gilbert, Arizona and 9 others

CompletedComprehensive Genetic Assessment, Risk and Education in a Mammography PilotResearchers are trying to learn more about the prevalence of genetic mutations in women who are at intermediate/high risk of breast cancer and how that information my assist…NCT04002986·Scottsdale, Arizona

Active not recruiting9-ING-41 in Patients With Advanced CancersGSK-3β is a potentially important therapeutic target in human malignancies.NCT03678883·Phoenix, Arizona and 65 others

UnknownBreast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept ProtocolThe major purpose of this study is to evaluate a laboratory developed test that measures multiple breast cancer-specific biomarker proteins and multiple antibodies in your blood…NCT02078570·Phoenix, Arizona and 11 others

CompletedEpothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast CancerThe purpose of this clinical research study is to learn if BMS-247550 added to the approved therapy of capecitabine (Xeloda) provides measurable clinical benefits over…NCT00082433·Tucson, Arizona and 185 others

RecruitingThe PREDICT Registry:This is a prospective, non-interventional (observational) cohort study conducted within the medical network of the participating investigators and institutions.NCT03448926·Scottsdale, Arizona and 29 others

CompletedA Phase III Trial For Patients With Metastatic Breast CancerThis is a phase III randomized study between the docetaxel/gemcitabine and docetaxel/ capecitabine doublets, with crossover to the alternate agent.NCT00191152·Glendale, Arizona and 64 others

CompletedS0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00016406·Mobile, Alabama and 313 others

Active not recruitingA Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)The primary purpose of this study is to determine the antitumor activity of enfortumab vedotin as measured by confirmed objective response rate (ORR) per RECIST v1.1.NCT04225117·Tucson, Arizona and 38 others

Active not recruitingStudy of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or LymphomasThis is a Phase 1/2a open-label, multicenter, dose escalation and dose expansion trial in which IMT-009 will be administered by the intravenous (IV) route to participants with…NCT05565417·Tucson, Arizona and 8 others

CompletedEvaluation of Lasofoxifene Combined With Abemaciclib in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 MutationThis is an open-label, multicenter, single-arm safety study evaluating the safety and tolerability of the lasofoxifene and abemaciclib combination for the treatment of pre- and…NCT04432454·Birmingham, Alabama and 15 others

RecruitingMulticenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic TherapyThis clinical trial studies eliminating surgery and/or radiation therapy in treating breast cancer patients.NCT02945579·Gilbert, Arizona and 7 others

PreviousPage 22 of 36Next

Other Conditions in Arizona

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma